NeoPharm Co (XKRX:092730) Operating Cash Flow per Share : ₩2,570.68 (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Operating Cash Flow per Share?

NeoPharm Co's operating cash flow per share for the three months ended in Mar. 2024 was ₩249.40. NeoPharm Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩2,570.68.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of NeoPharm Co was 2.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 11.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 3.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 19.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for NeoPharm Co's Operating Cash Flow per Share or its related term are showing as below:

XKRX:092730' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -34.7 Med: 14.45 Max: 124.9
Current: 11.2

During the past 13 years, NeoPharm Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 124.90% per year. The lowest was -34.70% per year. And the median was 14.45% per year.

XKRX:092730's 3-Year OCF Growth Rate is ranked better than
60.57% of 1405 companies
in the Consumer Packaged Goods industry
Industry Median: 4 vs XKRX:092730: 11.20

NeoPharm Co Operating Cash Flow per Share Historical Data

The historical data trend for NeoPharm Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Operating Cash Flow per Share Chart

NeoPharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

2,541.18

2,162.06

2,772.53

2,322.02

2,974.39

NeoPharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															653.32	725.91	579.73	1,015.65	249.40

Competitive Comparison of NeoPharm Co's Operating Cash Flow per Share

For the Household & Personal Products subindustry, NeoPharm Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeoPharm Co's Price-to-Operating-Cash-Flow Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, NeoPharm Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where NeoPharm Co's Price-to-Operating-Cash-Flow falls into.

NeoPharm Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

NeoPharm Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	23262.73	/	7.821
	=	2,974.39

NeoPharm Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	1949.322	/	7.816
	=	249.40

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,570.68

NeoPharm Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoPharm Co (XKRX:092730) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510

Website

http://www.neopharm.co.kr

NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines